Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan
- PMID: 35162443
- PMCID: PMC8834902
- DOI: 10.3390/ijerph19031421
Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan
Abstract
The Severe Acute Respiratory Syndrome-associated Coronavirus 2 (SARS-CoV-2) was an outbreak in December, 2019 and rapidly spread to the world. All variants of SARS-CoV-2, including the globally and currently dominant Delta variant (Delta-SARS-CoV-2), caused severe disease and mortality. Among all variants, Delta-SARS-CoV-2 had the highest transmissibility, growth rate, and secondary attack rate than other variants except for the new variant of Omicron that still exists with many unknown effects. In Taiwan, the pandemic Delta-SARS-CoV-2 began in Pingtung from 14 June 2021 and ceased at 11 July 2021. Seventeen patients were infected by Delta-SARS-CoV-2 and 1 person died during the Pingtung outbreak. The Public Health Bureau of Pingtung County Government stopped the Delta-SARS-CoV-2 outbreak within 1 month through measures such as epidemic investigation, rapid gene sequencing, rapidly expanding isolation, expanded screening of the Delta-SARS-CoV-2 antigen for people who lived in regional villages, and indirect intervention, including rapid vaccination, short lockdown period, and travel restrictions. Indirect environmental factors, such as low levels of air pollution, tropic weather in the summer season, and rural areas might have accelerated the ability to control the Delta-SARS-CoV-2 spread. This successful experience might be recommended as a successful formula for the unvaccinated or insufficiently vaccinated regions.
Keywords: Delta-variant; PCR fast screening; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); quarantine; rapid control; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan.Kaohsiung J Med Sci. 2023 Jun;39(6):624-636. doi: 10.1002/kjm2.12665. Epub 2023 Mar 23. Kaohsiung J Med Sci. 2023. PMID: 36951529 Free PMC article.
-
Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021.J Formos Med Assoc. 2022 Sep;121(9):1767-1772. doi: 10.1016/j.jfma.2022.01.008. Epub 2022 Jan 17. J Formos Med Assoc. 2022. PMID: 35067428 Free PMC article.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586. Int J Environ Res Public Health. 2022. PMID: 35457468 Free PMC article. Review.
-
SARS-CoV-2 Variants of Concern.Yonsei Med J. 2021 Nov;62(11):961-968. doi: 10.3349/ymj.2021.62.11.961. Yonsei Med J. 2021. PMID: 34672129 Free PMC article. Review.
Cited by
-
The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan.Kaohsiung J Med Sci. 2023 Jun;39(6):624-636. doi: 10.1002/kjm2.12665. Epub 2023 Mar 23. Kaohsiung J Med Sci. 2023. PMID: 36951529 Free PMC article.
-
Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment.PeerJ. 2023 Jan 23;11:e14666. doi: 10.7717/peerj.14666. eCollection 2023. PeerJ. 2023. PMID: 36710871 Free PMC article.
-
Co-detection of various viruses in SARS-CoV-2 in children with respiratory infections.Sci Rep. 2025 Mar 10;15(1):8312. doi: 10.1038/s41598-025-92878-w. Sci Rep. 2025. PMID: 40065003 Free PMC article.
-
Key risk factors associated with fractal dimension based geographical clustering of COVID-19 data in the Flemish and Brussels region, Belgium.Front Public Health. 2023 Nov 3;11:1249141. doi: 10.3389/fpubh.2023.1249141. eCollection 2023. Front Public Health. 2023. PMID: 38026374 Free PMC article.
-
Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination, and international travel across Belgian provinces in 2021.PLoS One. 2025 May 23;20(5):e0322017. doi: 10.1371/journal.pone.0322017. eCollection 2025. PLoS One. 2025. PMID: 40408410 Free PMC article.
References
-
- WHO Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021. [(accessed on 12 December 2021)]. Available online: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.....
-
- Challen R., Dyson L., Overton C.E., Guzman-Rincon L.M., Hill E.M., Stage H.B., Brooks-Pollock E., Pellis L., Scarabel F., Pascall D.J., et al. Early epidemiological signatures of novel SARS-CoV-2 variants: Establishment of B.1.617.2 in England. MedRxiv. 2021 doi: 10.1101/2021.06.05.21258365. - DOI
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous